Pharmaceutical grade silica gel market could worth $71.05 million by 2025
The global pharmaceutical grade silica gel market is projected to reach a market size of $71.05 million by 2025.
Pharmaceuticals, Biotechnology and Life Sciences
The global pharmaceutical grade silica gel market is projected to reach a market size of $71.05 million by 2025.
The consumption levels are anticipated to rise exponentially over the forecast period. The companies and government organizations are working collaboratively to bridge the gap between supply and demand.
The Global Pulmonary Drug Delivery Devices Market demonstrates a high degree of competition between GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, AstraZeneca Plc, Teva Pharmaceutical Industries Ltd., and Merck & Co. Inc.
Amryt has secured a patent in Japan for its skin disorder drug candidate Episalvan, and it is waiting to kick off the third phase clinical trial by the end of March 2017.
Advanced Oncotherapy has dropped taking legal measures against Sinophi Healthcare Limited (Sinophi), as the companies have agreed to terminate the purchase from March and October 2015.
Japan IP High Court confirmed validity of Eli Lilly’s Alimta vitamin regimen patents, and has invalidated trials initiated by Sawai regarding Lilly’s vitamin regimen patents for Alimta.
Akers Biosciences, a developer of rapid health information technologies, expects the total revenue for the 2016 year to be about…
India’s health ministry is likely to see a substantial increase in funding, after it warned that its programs were short of cash and sought more than $1.2 billion in additional money
Theradiag and its South Korean partners, Professor Chang-sik Yu and his team at Asan Medical Center and CbsBioscience will receive €1.3 million financial support from Eurostars program for its Pioneer collaborative project undertaken by its Prestizia molecular biology platform.
Beximco Pharmaceuticals has posted earnings of $1,113,722, for the second half of 2016, compared to $944,662 to the same period last year.